HER2 Alterations in NSCLC: Testing and Treatment Sequencing

  • Discuss evolving treatment landscape of HER2-directed therapies in NSCLC
  • Evaluate sequencing strategies for HER2-targeted ADCs and TKIs
  • Interpret the role of HER2 mutation and overexpression testing in clinical practice

EP. 1: Understanding HER2 Alterations in Non–Small Cell Lung Cancer

November 25th 2025

Explore innovative strategies for testing and treating HER2 alterations in non-small cell lung cancer through real-world case studies and expert insights.

EP. 2: Case 1: Managing HER2-Mutant NSCLC and ILD

November 25th 2025

Explore a case study on HER2 mutant lung cancer treatment, highlighting challenges and responses to therapy in a patient with metastatic disease.

EP. 3: Zongertinib After ADC Therapy: Efficacy, Safety, and Clinical Context

December 4th 2025

Explore a case study on HER2 mutant lung cancer treatment, highlighting challenges, responses, and the importance of monitoring for ILD.

EP. 4: Selecting Candidates for HER2 TKIs

December 4th 2025

Explore a case study on HER2 mutant lung cancer treatment, highlighting challenges and responses to chemotherapy and immunotherapy.